Shepherdson JL, Hutchison K, Don DW, McGillivray G, Choi TI, Allan CA, Amor DJ, Banka S, Basel DG, Buch LD, Carere DA, Carroll R, Clayton-Smith J, Crawford A, Dunø M, Faivre L, Gilfillan CP, Gold NB, Gripp KW, Hobson E, Holtz AM, Innes AM, Isidor B, Jackson A, Katsonis P, Amel Riazat Kesh L; Genomics England Research Consortium; Küry S, Lecoquierre F, Lockhart P, Maraval J, Matsumoto N, McCarrier J, McCarthy J, Miyake N, Moey LH, Németh AH, Østergaard E, Patel R, Pope K, Posey JE, Schnur RE, Shaw M, Stolerman E, Taylor JP, Wadman E, Wakeling E, White SM, Wong LC, Lupski JR, Lichtarge O, Corbett MA, Gecz J, Nicolet CM, Farnham PJ, Kim CH, Shinawi M (2024) Variants in ZFX are associated with an X-linked neurodevelopmental disorder with recurrent facial gestalt. American Journal of Human Genetics S0002-9297(24)00007-7 [doi: 10.1016/j.ajhg.2024.01.007]
McCarthy J, Yang J, Clissold B, Young MJ, Fuller PJ, Phan T (2021) Hypertension management in stroke prevention: Time to consider primary aldosteronism. Stroke 52(10):e626-e634 [doi: 10.1161/STROKEAHA.120.033990]
McCarthy J, Munnings M, Clissold B, Fuller PJ, Yang, J, Phan TG (2024) Prevalence of primary aldosteronism in acute stroke or transient ischemic attack: a systematic review and meta-analysis. Frontiers in Endocrinology [doi: 10.3389/fendo.2024.1355398]